Cargando…
Impact of exacerbations of cystic fibrosis on muscle strength
BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed wi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637497/ https://www.ncbi.nlm.nih.gov/pubmed/23601143 http://dx.doi.org/10.1186/1465-9921-14-46 |
_version_ | 1782267486872272896 |
---|---|
author | Burtin, Chris Van Remoortel, Hans Vrijsen, Bart Langer, Daniel Colpaert, Kristine Gosselink, Rik Decramer, Marc Dupont, Lieven Troosters, Thierry |
author_facet | Burtin, Chris Van Remoortel, Hans Vrijsen, Bart Langer, Daniel Colpaert, Kristine Gosselink, Rik Decramer, Marc Dupont, Lieven Troosters, Thierry |
author_sort | Burtin, Chris |
collection | PubMed |
description | BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. METHODS: QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. RESULTS: QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). CONCLUSIONS: QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity. |
format | Online Article Text |
id | pubmed-3637497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36374972013-04-27 Impact of exacerbations of cystic fibrosis on muscle strength Burtin, Chris Van Remoortel, Hans Vrijsen, Bart Langer, Daniel Colpaert, Kristine Gosselink, Rik Decramer, Marc Dupont, Lieven Troosters, Thierry Respir Res Research BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. METHODS: QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. RESULTS: QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). CONCLUSIONS: QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity. BioMed Central 2013 2013-04-19 /pmc/articles/PMC3637497/ /pubmed/23601143 http://dx.doi.org/10.1186/1465-9921-14-46 Text en Copyright © 2013 Burtin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Burtin, Chris Van Remoortel, Hans Vrijsen, Bart Langer, Daniel Colpaert, Kristine Gosselink, Rik Decramer, Marc Dupont, Lieven Troosters, Thierry Impact of exacerbations of cystic fibrosis on muscle strength |
title | Impact of exacerbations of cystic fibrosis on muscle strength |
title_full | Impact of exacerbations of cystic fibrosis on muscle strength |
title_fullStr | Impact of exacerbations of cystic fibrosis on muscle strength |
title_full_unstemmed | Impact of exacerbations of cystic fibrosis on muscle strength |
title_short | Impact of exacerbations of cystic fibrosis on muscle strength |
title_sort | impact of exacerbations of cystic fibrosis on muscle strength |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637497/ https://www.ncbi.nlm.nih.gov/pubmed/23601143 http://dx.doi.org/10.1186/1465-9921-14-46 |
work_keys_str_mv | AT burtinchris impactofexacerbationsofcysticfibrosisonmusclestrength AT vanremoortelhans impactofexacerbationsofcysticfibrosisonmusclestrength AT vrijsenbart impactofexacerbationsofcysticfibrosisonmusclestrength AT langerdaniel impactofexacerbationsofcysticfibrosisonmusclestrength AT colpaertkristine impactofexacerbationsofcysticfibrosisonmusclestrength AT gosselinkrik impactofexacerbationsofcysticfibrosisonmusclestrength AT decramermarc impactofexacerbationsofcysticfibrosisonmusclestrength AT dupontlieven impactofexacerbationsofcysticfibrosisonmusclestrength AT troostersthierry impactofexacerbationsofcysticfibrosisonmusclestrength |